ArticleEClinicalMedicine2025

Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China.

Ting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.